United States · FDA National Drug Code directory
Phenazopyridine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2750_47073c97-afea-4098-80fb-68d4bd2c6d00
- Product NDC
- 71335-2750
- Form
- TABLET
- Composition / generic term
- Phenazopyridine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20110201
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 TABLET in 1 BOTTLE (71335-2750-1) · 71335-2750-1
- 20 TABLET in 1 BOTTLE (71335-2750-2) · 71335-2750-2
- 30 TABLET in 1 BOTTLE (71335-2750-3) · 71335-2750-3
- 10 TABLET in 1 BOTTLE (71335-2750-4) · 71335-2750-4
- 15 TABLET in 1 BOTTLE (71335-2750-5) · 71335-2750-5
- 6 TABLET in 1 BOTTLE (71335-2750-6) · 71335-2750-6
- 90 TABLET in 1 BOTTLE (71335-2750-7) · 71335-2750-7
- 12 TABLET in 1 BOTTLE (71335-2750-8) · 71335-2750-8
- 18 TABLET in 1 BOTTLE (71335-2750-9) · 71335-2750-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →